BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Share Price

Certificat

IK58S

DE000SQ6UP04

Market Closed - Euronext Paris 10:00:01 10/05/2024 pm IST
0.763 EUR +14.22% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+42.62%
1 month-4.62%
Date Price Change Volume
10/24/10 0.763 +14.22% 94
09/24/09 0.668 +7.22% 99
08/24/08 0.623 +4.53% 100
07/24/07 0.596 +34.23% 99
06/24/06 0.444 +11.00% 94

Real-time Euronext Paris

Last update May 10, 2024 at 10:00 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
IK58S
ISINDE000SQ6UP04
Date issued 28/12/2022
Strike 209.7 CHF
Maturity Unlimited
Parity 20 : 1
Emission price 4.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.811
Lowest since issue 0.203

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Certificates
  3. IK58S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW